LEE'S PHARM (00950) repurchased 2,000 shares on November 9 for HK$2,140.
LEE'S PHARM (00950) announced that on November 9, 2026, the company repurchased 2,000 shares for HK$2,140, at a repurchase price of HK$1.07 per share.
LEE'S PHARM (00950) announced that on November 9, 2026, the company repurchased 2,000 shares for HK$2,140, at a repurchase price of HK$1.07 per share.
Related Articles
WuXi AppTec (02359) Removed from the 1260H List of Chinese Military Companies
RIBOLIFE-B (06938) submits an Investigational New Drug (IND) application for a Phase I clinical trial of the dual-target drug SR122 injection for the treatment of mixed dyslipidemia and severe hypertriglyceridemia.
Marvell Technology, Inc. (MRVL.US)'s US$115 billion "marriage of the century" has lost favor! The stock has fallen more than 40%, and experts estimate only a 50% probability of completion.
WuXi AppTec (02359) Removed from the 1260H List of Chinese Military Companies
RIBOLIFE-B (06938) submits an Investigational New Drug (IND) application for a Phase I clinical trial of the dual-target drug SR122 injection for the treatment of mixed dyslipidemia and severe hypertriglyceridemia.
Marvell Technology, Inc. (MRVL.US)'s US$115 billion "marriage of the century" has lost favor! The stock has fallen more than 40%, and experts estimate only a 50% probability of completion.
